| __timestamp | Amneal Pharmaceuticals, Inc. | Walgreens Boots Alliance, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 335989000 | 54823000000 |
| Thursday, January 1, 2015 | 367054000 | 76691000000 |
| Friday, January 1, 2016 | 420770000 | 87477000000 |
| Sunday, January 1, 2017 | 507476000 | 89052000000 |
| Monday, January 1, 2018 | 946588000 | 100745000000 |
| Tuesday, January 1, 2019 | 1273376000 | 91915000000 |
| Wednesday, January 1, 2020 | 1364130000 | 95905000000 |
| Friday, January 1, 2021 | 1324696000 | 104442000000 |
| Saturday, January 1, 2022 | 1427596000 | 104437000000 |
| Sunday, January 1, 2023 | 1573042000 | 112009000000 |
| Monday, January 1, 2024 | 121134000000 |
Igniting the spark of knowledge
In the ever-evolving landscape of the pharmaceutical and retail sectors, understanding cost dynamics is crucial. Over the past decade, Walgreens Boots Alliance, Inc. has consistently demonstrated a robust cost of revenue, peaking at approximately $112 billion in 2023, a 104% increase from 2014. This trend underscores the company's expansive growth and operational scale. In contrast, Amneal Pharmaceuticals, Inc. has shown a more modest trajectory, with its cost of revenue rising by 368% from 2014 to 2023, reaching around $1.57 billion. This growth reflects Amneal's strategic positioning in the pharmaceutical industry, albeit on a smaller scale compared to Walgreens. Notably, the data for 2024 is incomplete, highlighting the dynamic nature of financial forecasting. These insights provide a window into the financial strategies and market positioning of these industry giants, offering valuable lessons for stakeholders and investors alike.
Cost Insights: Breaking Down Novo Nordisk A/S and Walgreens Boots Alliance, Inc.'s Expenses
Cost of Revenue Trends: Incyte Corporation vs Amneal Pharmaceuticals, Inc.
Cost Insights: Breaking Down Viatris Inc. and Walgreens Boots Alliance, Inc.'s Expenses
Cost of Revenue Comparison: Intra-Cellular Therapies, Inc. vs Walgreens Boots Alliance, Inc.
Cost Insights: Breaking Down Walgreens Boots Alliance, Inc. and Alkermes plc's Expenses
Cost Insights: Breaking Down Walgreens Boots Alliance, Inc. and Agios Pharmaceuticals, Inc.'s Expenses
Analyzing Cost of Revenue: Walgreens Boots Alliance, Inc. and Mesoblast Limited
Comparing Cost of Revenue Efficiency: Exelixis, Inc. vs Amneal Pharmaceuticals, Inc.
Cost of Revenue Comparison: Alkermes plc vs Amneal Pharmaceuticals, Inc.
Cost of Revenue: Key Insights for Amneal Pharmaceuticals, Inc. and PTC Therapeutics, Inc.
Comparing Cost of Revenue Efficiency: Amneal Pharmaceuticals, Inc. vs Amphastar Pharmaceuticals, Inc.
Amneal Pharmaceuticals, Inc. vs Viridian Therapeutics, Inc.: Efficiency in Cost of Revenue Explored